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Summary
Objective: Small hyaluronan (HA) oligosaccharides displace HA from the cell surface and induce cell signaling events. In articular chondro-
cytes this cell signaling is mediated by the HA receptor CD44 and includes stimulation of genes involved in matrix degradation such as matrix
metalloproteinases (MMPs) as well as matrix repair genes including collagen type II, aggrecan and HA synthase-2 (HAS-2). The objective of
this study was to determine whether stimulation of HAS-2 and MMP-3 by HA oligosaccharides is due to the activation of a single, cascading
pathway or multiple signaling pathways.
Method: Bovine articular chondrocytes were pre-treated with a variety of inhibitors of major signaling pathways prior to the addition of HA
oligosaccharides. Changes in HA were monitored by real time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of
HAS-2 mRNA, HA ELISA and HA accumulation at the cell surface. A 1900 base pair sequence containing the proximal promoter of HAS-2
was inserted into a luciferase reporter construct, transfected into human immortalized chondrocytes and assayed in a similar fashion.
Results: While our previous studies demonstrated that HA oligosaccharides stimulate MMP-13 activity via activation of p38 MAP kinase and
NF-kB, inhibitors of these pathways did not affect the stimulation of HAS-2 mRNA expression. However, inhibiting the phosphatidylinositol-3-
kinase pathway blocked HA oligosaccharide-mediated stimulation of HAS-2 yet had no effect on MMP-3. Wortmannin and LY294002 also
blocked HA oligosaccharide-induced serine and threonine Akt phosphorylation. Treatment of transfected immortalized chondrocytes with
HA oligosaccharides resulted in stimulation of HAS-2 mRNA, activation of Akt and enhanced luciferase activitydactivity that was blocked
by inhibitors of Akt phosphorylation.
Conclusions: Changes in chondrocyteematrix interactions by HA oligosaccharides induce altered matrix metabolism by the activation of least
two distinct signaling pathways.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Many connective tissue cells exhibit a large hyaluronan
(HA) and proteoglycan-rich pericellular matrix that is teth-
ered to the cell surface via interactions with the HA receptor,
CD441,2. HA oligosaccharides, of the size of a HA hexasac-
charide or larger, can compete with the binding of high mo-
lecular mass HA to CD44 and competitively displace HA
(and the proteoglycan-rich pericellular matrix) from the cell
surface1e7. In addition to the physical loss of this cell-asso-
ciated pericellular matrix, the uncoupling of HA from CD44
gives rise to signal transduction eventsdresponses that dif-
fer depending on the cell type2,3,6e9. In some cells, such as
chondrocytes, HA polysaccharide bound at the cell surface
represents the quiescent state. Thus, the binding of a ligand
alone is not the inductive signal. Under these conditions,
HA oligosaccharides function as speciﬁc HA antagonists.*Address correspondence and reprint requests to: Warren
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447The best model currently is that CD44 is clustered at the
plasma membrane by way of multivalent interactions with
high molecular mass HAdclustering that is reversed by ad-
dition of excess monovalent HA oligosaccharides3,10. The
transmembrane receptor CD44 has a 72 amino acid intra-
cellular tail domain but no inherent kinase activity. Thus,
signaling events induced by HA oligosaccharide uncluster-
ing of CD44 likely involve the activation of CD44-associated
proteins including changes in the cytoskeletal components.
In articular cartilage, chondrocytes sense and respond to
changes in their extensive extracellular matrix10,11. In oste-
oarthritis, early events in the degenerative process may be
initiated by changes in chondrocyteematrix interactions. To
explore the role of HA and CD44 in these processes, intact
cartilage slices were treated with HA oligosaccharides to ef-
fect a displacement of the HA-rich matrix from the
chondrocyte cell surface. In our previous study, HA oligo-
saccharides initiated a chondrocytic chondrolysis cascade
including a dramatic loss of safranin O staining8. This cas-
cade included initiation of proteolytic events including the
activation of several matrix metalloproteinases (MMPs) as
well as an increase in NITEGE neoepitope8 (indicative of
aggrecan cleavage by ADAMTS-5 or other aggreca-
nases12). This catabolic activation could be modeled by
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alginate beads, with HA oligosaccharides. Interestingly
however, in addition to the stimulation of MMP-3, MMP-13
and nitric oxide, there was also a stimulation of genes
involved in the biosynthesis of extracellular matrix, such
as aggrecan, cartilage oligometric matrix protein (COMP)
and collagen type II8,9,13e16. HA synthase-2 (HAS-2)
mRNA was also upregulated following treatment of chon-
drocytes with HA oligosaccharides8,16. Thus, there is an ap-
parent coordination between HA oligosaccharide-mediated
stimulation of matrix degradation and matrix biosynthesis.
The objective of this study was to determine whether these
opposing events represented the activation of a single, cas-
cading pathway or the activation of multiple signaling path-
ways. One hypothesis would be that the stimulation of
matrix biosynthesis represents an ‘‘attempted repair’’ phase
by the chondrocytes in response to the stimulation/activa-
tion of cartilage chondrolysis. If this were the case, blocking
the signaling pathways responsible for MMP stimulation
would block downstream stimulation of new matrix biosyn-
thesis. In addition, stimulation of matrix biosynthesis would
occur at time points later than those observed for MMPs or
nitric oxide. In the current study we demonstrate that the
HA oligosaccharide stimulation of at least one anabolic
gene, HAS-2, occurs in 6 h. Additionally, the stimulation of
HAS-2 mRNA expression and HAS-2 promoter luciferase
activity were not inhibited by chemical inhibitors that block
HA oligosaccharide-mediated stimulation of MMPs.MethodsCELL CULTUREChondrocytes were isolated from full thickness slices of the articular sur-
face of the metacarpophalangeal joints of 18e24 month old adult bovine
steers17. The cartilage slices were digested in 0.2% pronase (Calbiochem,
San Diego, CA) in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Mediatech,
Herndon, VA) plus 10% fetal bovine serum (FBS; Hyclone) for 1.5 h at 37C,
followed by an overnight digestion with 0.025% collagenase-P (Calbiochem)
in DMEM containing 10% FBS. Primary chondrocytes were plated as high-
density monolayers (4 106 cells/35 mm2 dishes) in DMEM supplemented
with 50 units/ml penicillin (Mediatech), 50 mg/ml streptomycin (Mediatech)
and 10% FBS and incubated at 37C in an atmosphere containing 5%
CO2. The immortalized human chondrocyte cell line (C-28/I2) was kindly pro-
vided by Dr. Mary Goldring (Hospital for Special Surgery, New York). C-28/I2
cells were maintained in a 1:1 mixture of DMEM/Ham’s F12 medium contain-
ing 10% FBS.HA OLIGOSACCHARIDESHA from human umbilical cord or rooster comb (Sigma) was used to gen-
erate HA oligosaccharides by testicular hyaluronidase (type I-S; Sigma)
cleavage at a ratio of 320 units/mg HA in 0.1 M sodium acetate buffer with
0.15 M NaCl, pH 5.018. Digestion conditions of 16 h at 37C yielded prepara-
tions with a predominant peak of HA hexasaccharides by chromatographic
analysis8. At the end of the reaction, the hyaluronidase was heat-inactivated
and then precipitated with 10% trichloroacetic acid. The oligosaccharide-con-
taining supernatant was dialyzed in 1000 molecular weight cut-off (MWCO)
dialysis tubing (Spectrum Medical Industries, Houston, TX) with four changes
of H2O over 48 h, lyophilized to dryness and then redissolved in sterile phos-
phate buffer saline (PBS). As a control, HA disaccharides (HA2) were gener-
ated from the HA oligosaccharides by treatment with 10 units/ml
chondroitinase ABC8.REAL TIME REVERSE TRANSCRIPTASE-POLYMERASE CHAIN
REACTION (RT-PCR)Total RNA was isolated from the bovine chondrocytes or C-28/I2 cultures
using TRI Reagent (Sigma) according to the manufacturer’s instructions.
Samples were reverse transcribed and PCR ampliﬁed using OneStep RT
qPCR Master Mix for SYBR Green I (Eurogentec, San Diego, CA). The
primer-speciﬁc annealing temperature (AT) and detection temperature (DT)
cycles were run at the following temperatures: glyceraldehyde-3-phosphatedehydrogenase (GAPDH), AT 57C, DT 74C; HAS-2 and MMP-3, AT
55C, DT 72C. The DTs were set below the individual melting peak of
each PCR product. The PCR primer sets were: GAPDH (forward: 50-
GTCAACGGATTTGGTCGTATTGGG-30, reverse: 50-TGCCATGGGTGGA
ATCATATTGG-30); MMP-3 (forward: 50-CTCACAGACCTGACTCGGTT-30,
reverse: 50-CACGCCTGAAGGAAGAGATG30) and; HAS-2 (forward: 50-
GAGGACGACTTTATGACCAAGAGC-30, reverse: 50-TAAGCAGCTGTGAT
TCCAAGGAGG-30). Thermal cycling and ﬂuorescence detection was per-
formed using the Smart Cycler system (Cepheid, Sunnyvale, CA). Efﬁciency
(E ) of the real time PCR was calculated according to the equation by Ras-
mussen et al.19 as E¼ 10(1/slope) for GAPDH, HAS-2 and MMP-3. The slope
was determined from a graph of x¼ ng cDNA input and y¼ cycle number at
the crossing point (CP). The CP is the PCR cycle number determined by the
Smart Cycler software as the peak of second derivative curve of the increase
in SYBR Green ﬂuorescence as ampliﬁcation proceeds. A value for fold
increase was calculated as a relative ratio of a target gene (e.g., HAS-2)
to GAPDH, following the mathematical model and equation introduced by
Pfafﬂ20. Using this equation, the fold increase in mRNA copy numbers of
target mRNAs HAS-2 or MMP-3, between treated and untreated control
conditions, can be determined.
Fold increase¼

Etarget
CP target ðMEAN control e MEAN treatedÞ
ðEGAPDHÞCP GAPDH ðMEAN control e MEAN treatedÞGENERATION OF A HAS-2 PROMOTER CONSTRUCTPCR primers were designed to amplify a DNA region within the HAS-2
gene extending from 1774 to þ160 base pairs with respect to the transcrip-
tional start site described by Monslow et al.21. The primers were engineered
to include restriction enzyme sites for Mlu I and Bgl II on the 50 ends of the
forward and reverse primers, respectively: forward 50-GAGACGCGTATTTA-
GAGCTGGAAGGTTAAGT-30 and reverse 50-GAGCTCAGATCTATGGTT-
CAATGGGCTC-30. Puriﬁed human genomic DNA (Promega) was PCR
ampliﬁed using Pfx taq polymerase (Invitrogen, Carlsbad, CA) with AT of
55C and extension temperature of 68C for 30 cycles. The PCR products
were puriﬁed and cloned into a pCR2.1 TOPO vector plasmid (Invitrogen).
The TOPO plasmid DNA insert was then subcloned into the pGL3-basic
plasmid (Promega) using the restriction enzymes Mlu I and Bgl II and given
the designation pHAS2 (1932)-Luc. All inserts were veriﬁed by restriction di-
gest analysis and DNA sequencing at the University of Illinois sequencing
laboratory core facility.TRANSIENT TRANSFECTIONSThe human immortalized chondrocytes (C-28/I2) were plated 24 h prior to
transfection at a density of 1 105 cells/well in 12-well plates and transiently
transfected with 1 mg of the pHAS2 (1932)-Luc construct using FuGENE 6
transfection reagent (Roche Applied Science) following the manufacturer’s
instructions. The ﬁreﬂy luciferase promoterless vector, pGL2-Enhancer
(Promega) was used as a control. After 24 h of incubation, the cells were
rinsed in PBS and changed to serum-free condition for 20e24 h followed
by treatment with 250 mg/ml HA6 or 1 ng/ml interleukin-1alpha [IL-1a (R&D
Systems, Minneapolis, MN)]. The cells were harvested after 24 h, and
luciferase activity was assayed using a luciferase reporter assay system
(Promega). The data were normalized to total protein levels in each well.TREATMENT OF CELLS WITH CHEMICAL INHIBITORS OF
MAJOR SIGNALING PATHWAYSCells were brought to serum-free conditions by incubation in 1% FBS for
24 h and then to 0% for the start of the experiment. Chondrocytes were in-
cubated with 250 mg/ml HA oligosaccharides for time periods between
0 and 24 h. For signaling inhibition assays, bovine chondrocytes were pre-
treated with inhibitors of NF-kB (1 mM Helenalin, Calbiochem); p38 MAP
kinase (5 mM SB203580, Calbiochem); Src kinase (10 mM PP2, Calbio-
chem); MAP kinase (MEK1/2, 10 mM PD98059, Calbiochem) or; phosphati-
dylinositol-3-kinase (PI3K)/Akt (100 nM Wortmannin, Sigma or; 25 mM
LY294002, Calbiochem) for 30 min and then, treated with 250 mg/ml HA oli-
gosaccharides for 0e24 h in the presence or absence of each inhibitor.WESTERN BLOTTING OF AKT PHOSPHORYLATIONFollowing incubation in the absence or presence of HA oligosaccharides
or pathway inhibitors, the chondrocyte cell layers were extracted with cell
lysis buffer (Cell Signaling Technology, Inc., Danvers, MA) and 1 protease
and phosphatase inhibitors cocktail (Sigma). The cell lysates were separated
by a 10% SDS-PAGE and electroblotted onto nitrocellulose membranes. The
nitrocellulose membranes were blocked with 5% nonfat dry milk in TBS
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with anti-phospho-Akt (ser473 and thr308) rabbit monoclonal antibody (Cell
Signaling Technology, Inc.). Detection was performed using chemilumines-
cence (Western Blotting Luminol Reagent, Santa Cruz Biotechnology). After
imaging, the blots were stripped for 30 min at 50C and re-probed using rab-
bit monoclonal antibodies directed against total Akt (Cell Signaling Technol-
ogy, Inc.) or b-actin (AC-15; Sigma).CASEIN ZYMOGRAPHYSerum-free conditioned medium samples (30 ml) were activated with
2.5 mM aminophenylmercuric acetate (APMA) for 1 h at 37C and then sep-
arated by 12% SDS-PAGE containing casein (Invitrogen). The gels were
washed twice, 30 min each, in zymogram renaturing buffer (Invitrogen) and
then incubated overnight at 37C in zymogram developing buffer (Invitrogen)
containing APMA. The gels were then stained with 1% Coomassie R-250
blue in 40% ethanol and 10% acetic acid for 1 min with microwave heating
at full power and then 15 min at room temperature. De-staining included
1 min microwave heating at full power and incubation at room temperature
in 10% ethanol and 7.5% acetic acid until clear bands over a dark back-
ground were observed. The bands were imaged and quantiﬁed using the ﬂu-
orimaging system (Fluor-S MultiImager, Bio-Rad, Hercules, CA).IMMUNOFLUORESCENCE MICROSCOPY AND HA ELISAFig. 1. Time course for the stimulation of HAS-2 mRNA by HA
oligosaccharides. Panel A: Total RNA was isolated from bovine
articular chondrocytes, reverse transcribed into cDNA for HAS-2
or GAPDH and ampliﬁed by PCR. Following ampliﬁcation, the
temperature was gradually increased and the loss of SYBR green
ﬂuorescence was monitored. The presence of a single Tm value
is indicative of a single PCR product in the reaction mixture. The
ﬁnal cDNA products were also separated by electrophoresis on
a 1.5% agarose gel and exhibited the correct predicted size of
142 bp and 121 bp for GAPDH and HAS-2 respectively. As a con-
trol, real time RT-PCR reactions were performed under conditionsFor these experiments, chondrocytes were treated without or with HA
oligosaccharides for 8 h, rinsed to remove HA oligosaccharides, followed
by a 24 h incubation and subsequent collection of the conditioned media.
The media samples were assayed for HA using a HA ELISA (DuoSet,
R&D) that probes using biotinylated recombinant aggrecan (N-terminal pep-
tide). Chondrocyte monolayers in 4-well chamber slides (105/well) were
ﬁxed in 2% paraformaldehyde in PBS, pH 7.4 for 1 h, quenched with
0.2 M glycine in PBS and blocked in 1% bovine serum albumin (BSA,
Sigma) in PBS for 1 h. The cells were then incubated with 2.0 mg/ml of a bio-
tinylated-HA binding protein (HABP) probe (Seikagaku USA, Ijamsville, MD)
for 2 h at room temperature for HA detection. Following extensive washing,
the cells were incubated with 1 mg/ml neutravidin-FITC (1:1000) (Molecular
Probes, Inc., Eugene, OR) in PBS containing 1% BSA for 1 h at 4C. The
cells were then washed, mounted in mounting media containing the nuclear
stain, 40,6-diamidino-2-phenylindole, dihydrochloride (DAPI; Molecular
Probes) and visualized using a Nikon Eclipse E600 microscope equipped
with Y-Fl Epi-ﬂuorescence (Melville, NY). Images were captured digitally
in real time using a Spot-RT camera (Diagnostic Instruments, Sterling
Heights, MI) and processed using NIS Elements BR imaging software
(Nikon, Lewisville, TX).in which the reverse transcriptase was absent from the reaction
mixture, lanes 7 and 14. A similar evaluation was determined sep-
arately for total RNA derived from C-28/I2 chondrocytes and for the
efﬁciency of MMP-3 primers. Panel B: Bovine articular or C-28/I2Resultschondrocytes cultured in monolayer in DMEM/Ham’s F12 were
brought to serum-free conditions (0 h) and then incubated for 3,TIME COURSE FOR THE STIMULATION OF HAS-2 MRNA BY HA
OLIGOSACCHARIDES
6, and 24 h with or without 250 mg/ml HA oligosaccharides under
serum-free conditions. C-28/I2 cells were also treated for 24 h
with 250 mg/ml HA2 derived from HA oligosaccharides by chondroi-
tinase ABC treatment. Total RNA was isolated, reverse transcribed
into cDNA and PCR ampliﬁed with SYBR green. The fold change in
HAS-2 copy number values represent the averageS.D. of data
derived from triplicate cultures, assayed in triplicate. Fold increases
from 6 to 24 h treated chondrocytes and C-28/I2 cells exhibited sig-
niﬁcant differences from control; *P< 0.05, **P< 0.01 respectively
as measured using an unpaired Student’s t test.Primer sets for real time PCR ampliﬁcation and quantiﬁ-
cation of bovine HAS-2 and GAPDH were designed and
validated. As shown in Fig. 1(A), aliquots of total RNA
were reverse transcribed and PCR ampliﬁed in triplicate
for each primer set. Each primer set generated a consistent,
single melt curve for both GAPDH and HAS-2 cDNA, indic-
ative of a single product. The generation of a single product
was also conﬁrmed by agarose gel electrophoresis of ampli-
ﬁed products, each of the expected product size. Ampliﬁca-
tion efﬁciencies for each primer set were also determined
allowing the comparison of mRNA copy numbers between
treated vs control cultures, normalized to GAPDH. As
shown in Fig. 1(B), no change in the ratio of copy numbers
for HAS-2 was observed following 3 h of incubation with HA
oligosaccharides. However, after 6 h of incubation with the
HA oligosaccharides, there was a 2.7-fold increase in
HAS-2 mRNA copy number as compared to untreated
chondrocytesdan increase still detected at the 24 h time
point. C-28/I2 immortalized human chondrocytes are often
used as a model system to study signal transduction.
C-28/I2 cells treated with HA oligosaccharides also
exhibited an increase in HAS-2 mRNA at 6 and 24 h
[Fig. 1(B)]. However, if the same HA oligosaccharides, atthe same concentration, were predigested to HA2 using
chondroitinase ABC, no signiﬁcant stimulation of C-28/I2
HAS-2 mRNA was observed.
As an approach to link the stimulation of HAS-2 mRNA to
enzyme activity, changes in the production of HA itself were
documented. As shown in Fig. 2(A), treatment of bovine
chondrocytes with HA oligosaccharides resulted in a 7.6-
fold increase in HA secreted into the culture medium. More-
over, treatment with HA oligosaccharides also resulted in
a substantial enhancement of cell surface-associated HA
[green ﬂuorescence, Fig. 2(C vs B); detected using a HA-
speciﬁc biotinylated HA binding protein]. The enhancement
Fig. 2. Changes in medium and cell surface HA after treatment with
HA oligosaccharides. Bovine articular chondrocytes were treated
for 8 h in the presence or absence of 250 mg/ml HA oligosaccha-
rides in serum-free DMEM/Ham’s F12 medium, followed by an ad-
ditional 24 h of culture in fresh, serum-free DMEM/Ham’s F12
medium. Panel A: Aliquots of the culture medium were then ana-
lyzed by ELISA for HA content following comparison to HA stan-
dard curve. Treatment increased HA signiﬁcantly above control;
**P< 0.01 as measured using an unpaired Student’s t test. After
washing the cell layer, the chondrocytes were incubated with a bio-
tintylated HABP probe, washed, incubated with neutravidin-FITC
and mounting medium containing DAPI. The chondrocytes were vi-
sualized by ﬂuorescence microscopy using a Nikon E600 micro-
scope with a 20 objective. Panel B: Control chondrocytes
cultured in serum-free DMEM/Ham’s F12 medium without HA
450 I. Schmitz et al.: Oligosaccharide stimulation of HAS-2was quantiﬁed by morphometric analysis as shown in
Table I. HA oligosaccharide-treated chondrocytes exhibited
a 1.5-fold increase in values for maximal green ﬂuores-
cence pixel intensity above untreated control cells. How-
ever, as seen if Fig. 2(B), while the ﬂuorescence intensity
itself is only enhanced 1.5-fold above control cells, there
is also a substantial difference in the size of the pericellular
matrices. The sum of pixel intensities in the area delineated
by the observable FITC-pericellular matrices of HA oligo-
saccharide-treated chondrocytes was 2.3 times the
summed intensities of untreated control cells (Table I).
This was also reﬂected by an increase in the overall area
delineated by the HA oligosaccharide-treated chondro-
cytes. These HA production data suggest the 2.7-fold in-
crease in HAS-2 mRNA (Fig. 1) is matched by an
increase in HAS-2 protein activity.EFFECT OF CHEMICAL INHIBITORS OF SIGNALING PATHWAYS
ON THE STIMULATION OF HAS-2 MRNA BY HA
OLIGOSACCHARIDESChemical inhibitors of NF-kB (Helenalin) and the p38
MAP kinase (SB203580) pathway that blocked HA oligo-
saccharide-induced increases in MMP-1315 were used to
determine their effects on HAS-2 mRNA stimulation. In con-
trol chondrocyte cultures, without added inhibitor, there was
a >3-fold increase in HAS-2 mRNA following 24 h of expo-
sure to HA oligosaccharides [Fig. 3(A)]. Upon pretreatment
with the NF-kB pathway inhibitor Helenalin or the p38 MAP
kinase inhibitor SB203580 (at the same concentrations that
inhibited stimulation of MMP-13 mRNA15), an increase in
HA oligosaccharide-induced HAS-2 expression was still ob-
served. Similar results were obtained using another NF-kB
pathway inhibitor, SN50 (data not shown). Previous studies
by others using the general Src kinase inhibitor, PP2 had
suggested the participation of Src kinase in mediating met-
abolic changes induced by HA oligosaccharides22,23. How-
ever, as shown in Fig. 3(A), pretreatment with PP2 also did
not block the stimulation of HAS-2. Other investigators dem-
onstrated that HA oligosaccharides induce apoptosis in an-
chorage-independent tumor cell lines via the PI3K/Akt
pathway3. Two reagents, Wortmannin and LY294002 are
commonly used to block the phosphorylation of Akt. As
shown in Fig. 3(A), LY294002 affected a small decrease
in HAS-2 mRNA in control cells. However, both Wortmannin
and LY294002 pretreatments effectively blocked the HA ol-
igosaccharide-induced stimulation of HAS-2 mRNA.
These data suggested that the stimulation of MMPs and
HAS-2 by HA oligosaccharides were mediated by separate
signaling pathways. To further validate this hypothesis, we
determined the effect of PI3K/Akt pathway inhibitors on
MMP-3 expression. As shown in Fig. 3(B), HA oligosaccha-
rides affected an approximately 5-fold increase in MMP-3
mRNA expression as determined by real time RT-PCR.
While both Wortmannin and LY294002 affected a small in-
crease in MMP-3 mRNA in control cells, neither reagent sig-
niﬁcantly blocked the stimulation of MMP-3 expression
following treatment with HA oligosaccharides. Using anoligosaccharides. Panel C: Chondrocytes cultured in the presence
of 250 mg/ml HA oligosaccharides in serum-free DMEM/Ham’s F12
medium. The images shown depict representative two-color digital
overlays of green and blue ﬂuorescence images captured sepa-
rately (of six ﬁelds of view from two separate experiments).
Bar¼ 20 mm.
Table I
Morphometric analysis of changes in cell-associated HA in bovine articular chondrocytes
Parameter Control chondrocytes HAoligo treated Fold change Signiﬁcance
Maximal pixel intensity* 133 44 (n¼ 34) 194 40 (n¼ 35) 1.5 P< 0.0001x
Sum of pixel intensitiesy 244 174 (n¼ 35) 557 336 (n¼ 35) 2.3 P< 0.0001
Cell-associated areaz 32 25 (n¼ 33) 89 41 (n¼ 35) 2.7 P< 0.0001
*Values for maximal pixel intensity.
ySum of pixel intensities (103) S.D. for each cell condition were obtained by analysis of regions of the cell-associated area (cellþ pericel-
lular matrix) for each cell using Nikon NIS Elements BR 2.30 Image Analysis software (255¼maximal value per channel). Software provides
a value for maximum or sum of pixel intensities within a deﬁned region.
zValues for the area of cell-associated matrices S.D. were determined by trace of the total cellþ pericellular matrix perimeter for each cell
using Bio-Rad Quantity One 4.6.1 image analysis software. Values denote mm2 of cell-associated area/cell as imaged on a Raw 1-D image of
a 20 ﬁeld of view of chondrocytes.
xDenotes P-value for statistical signiﬁcance between values for control and HA oligosaccharide (HAoligo) treated cell cultures as measured
using an unpaired Student’s t test.
451Osteoarthritis and Cartilage Vol. 18, No. 3alternative approach, MMP activity was visualized by ca-
seinolytic zymography. As shown in Fig. 3(C), whereas Hel-
enalin completely blocked HA oligosaccharide-mediated
stimulation of caseinolytic activity bands, LY294002 ex-
hibited only a slight inhibition of this activity. In this experi-
ment, the size of the predominant, activated caseinolytic
band was w45 kD, indicative (although not deﬁnitive) of
MMP-3.EFFECT OF WORTMANNIN AND LY294002 ON AKT
PHOSPHORYLATIONTo further substantiate the participation of the PI3K path-
way in response to HA oligosaccharide treatment of chon-
drocytes, the effects on Akt phosphorylation were
explored. Figure 4(A) depicts a western blot analysis of ly-
sates derived from bovine articular chondrocytes probed
with an antibody to Akt phosphorylated at the thr308 residue.
Following treatment with HA oligosaccharides for 3 h, a sub-
stantial activation of Akt was observed [Fig. 4(A, lane 4)] as
compared to control cells (lane 1). This level of activation
was similar in intensity to the positive control, chondrocytes
treated with bFGF [Fig. 4(A, lane 5)]. However, chondro-
cytes treated with HA oligosaccharides in the presence of
Wortmannin exhibited a substantially diminished activation
of Akt [Fig. 4(A, lane 3)].
Human C-28/I2 chondrocytes also displayed a time-de-
pendent increase in Akt activation following exposure to
HA oligosaccharides [Fig. 4(B)]. With these cells, the stron-
gest response was observed using antibodies directed to-
ward phosphorylation of Akt ser473. In another experiment,
C-28/I2 cells treated with HA oligosaccharides for 30 min
exhibited activation of Akt, observed by thr308 and ser473
phosphorylation, with ser473 phosphorylation displaying
the strongest response [Fig. 4(C, lane 2)]. Pretreatment
with Wortmannin (lane 4) or LY294002 (lane 6) again
blocked the HA oligosaccharide-stimulated activation of
Akt. Thus, C-28/I2 cells exhibit HA oligosaccharide-induced
induction of HAS-2 mRNA [Fig. 1(B)] and activation of PI3K/
Akt pathway.EFFECT OF CHEMICAL INHIBITORS OF SIGNALING PATHWAYS
ON THE STIMULATION BY HA OLIGOSACCHARIDES OF HAS-2
PROMOTER ACTIVITYA region approximately 2000 bp upstream from the tran-
scriptional start site21 of the human HAS-2 was identiﬁed
as a potential promoter region using the web based program‘‘zPicture’’ (a dynamic blastz alignment visualization pro-
gram) located at http://zpicture.dcode.org/. The localization
of potential cis element transcription factor sites within this
region homologous to mouse and human were identiﬁed
using the web based program; ‘‘Regulatory Vista’’ (rVista)
at http://rvista.dcode.org/and, ‘‘MatInspector’’ at http://www.
genomatix.de/products/MatInspector/index.html. Based on
these data, a 1932 bp region upstream of the
transcriptional start site was subcloned into a pGL3
luciferase plasmid as depicted in Fig. 5(A). The HAS-2
promoter construct, given the designation pHAS2 (1932)-
Luc, was transfected into C-28/I2 immortalized human
chondrocytes and assayed for luciferase activity. In
untreated control cells, the basal luciferase activity of the
pHAS2 (1932)-Luc was approximately 7-fold higher that the
pGL3-basic plasmid with no insert (data not shown). As
shown in Fig. 5(B), treatment with HA oligosaccharides for
24 h resulted in w2-fold increase in luciferase activity,
as compared to transfected untreated cells. These results
demonstrate that the pHAS2 (1932)-Luc construct contains
a region of the human HAS-2 promoter/enhancer
sequence that is responsive to signaling events initiated by
HA oligosaccharides. No changes in responsiveness of the
pHAS2 (1932)-Luc to HA oligosaccharides was observed
when the cells were cultured in the presence of chemical
inhibitors of the MEK kinase (PD98059), p38 MAP kinase
(SB203580) or NF-kB pathways [Helenalin, Fig. 5(B)]. For
as yet unknown reasons, the presence of Helenalin
enhanced the effect of HA oligosaccharides on pHAS2
(1932)-Luc activity. On the other hand, both Wortmannin
and LY294002 blocked the HAS-2 promoter-driven
luciferase activity. This evidence further supports the
previous experiments that inhibitors to PI3K pathway block
the HA oligosaccharide-mediated stimulation of HAS-2. In
data not shown, no changes in C-28/I2 cell viability were
observed in cells treated with PD98059, SB203580,
Wortmannin and LY294002 with or without co-incubation
with HA oligosaccharides.Discussion
Functional disarrangement of the pericellular cartilage
matrix occurs during osteoarthritis including changes in ag-
grecan and collagens24. Previous studies by others have
demonstrated the coordinate biosynthesis of HA and aggre-
can by chondrocytes25. In this study, HA oligosaccharides
were used as a tool to disrupt HAeCD44 interactions in
Fig. 3. Effect of chemical inhibitors of signaling pathways on HA
oligosaccharide-mediated stimulation of HAS-2 and MMP-3 in
bovine articular chondrocytes. Panel A: Bovine articular chondro-
cytes cultured in monolayer in DMEM/Ham’s F12 were brought
to serum-free conditions and then preincubated with or without
chemical inhibitors: PP2, Helenalin, SB203580, Wortmannin
(Wort) or LY294002, 30 min prior to, and during the addition or
absence of 250 mg/ml HA oligosaccharides (HAoligo) under
serum-free conditions. Total RNA was isolated, reverse transcribed
into cDNA and PCR ampliﬁed using SYBR green. The fold change
in HAS-2 mRNA copy number values represent the averageS.D.
of data derived from triplicate cultures. Fold increases following HA
oligosaccharide treatment, in control (no inhibitor), PP2, Helenalin
and SB203580 conditions represented signiﬁcant increases above
control; P¼ 0.0037, 0.0486, 0.0116 and 0.0022, respectively as
measured using an unpaired Student’s t test. Panel B: Another
set of bovine articular chondrocyte cultures were preincubated
with or without the chemical inhibitors Wortmannin or LY294002,
30 min prior to, and during the addition of 250 mg/ml HA oligosac-
charides under serum-free conditions. The fold change in MMP-3
mRNA copy number between control and treated cultures was
determined as described in panel A. Fold increases following HA
oligosaccharide treatment, in control (no inhibitor), Wortmannin
(Wort) or LY294002 conditions represented signiﬁcant increases
above control; P¼ 0.00007, 0.0003, and 0.0004, respectively as
measured using an unpaired Student’s t test. Panel C: Conditioned
medium from chondrocytes treated with or without 250 mg/ml HA
oligosaccharides ( þ HAoligo) under serum-free conditions, with
or without Helenalin or LY294002 were processed for casein
zymography. The gel image shown was digitally inverted to gener-
ate dark bands on a light background.
Fig. 4. Effect of chemical inhibitors of the PI3-kinase pathway and
HA oligosaccharides on Akt phosphorylation. Panel A: Bovine artic-
ular chondrocytes cultured in monolayer in DMEM/Ham’s F12 were
brought to serum-free conditions and then preincubated with the
chemical inhibitor, Wortmannin, 30 min prior to, and during the ad-
dition of 250 mg/ml HA oligosaccharides for 3 h. Chondrocytes were
washed, solubilized with cell lysis buffer and processed for western
blot analysis on 10% SDS-PAGE gels. The western blot was
probed using antibodies speciﬁc for Akt phosphorylated at thr308.
Lane 1 is lysate derived from untreated control cells (Ctr); lane 2,
chondrocytes treated with Wortmannin (Wort); lane 3, cells treated
wi th Wor tmann in and 250 mg/ml HA ol igosacchar ides
(WortþHAoligo); lane 4, cells treated with HA oligosaccharides
alone (Ctr þHAoligo), and; lane 5, chondrocytes treated with
bFGF. Following visualization the western blot was stripped and
re-probed for total Akt. Panel B: C-28/I2 cells cultured in monolayer
in DMEM/Ham’s F12 were brought to serum-free conditions and
then incubated with 250 mg/ml HA oligosaccharides for 0, 15, 30,
60, 180 or 360 min. Cell lysates were probed using antibodies spe-
ciﬁc for Akt phosphorylated at ser473. Following visualization the
western blots were stripped and re-probed for total Akt and b-actin.
Panel C: C-28/I2 cells cultured in monolayer in DMEM/Ham’s F12
were brought to serum-free conditions and then preincubated with
the chemical inhibitors, Wortmannin (Wort) or LY294002 (LY),
30 min prior to, and during the addition of 250 mg/ml HA oligosac-
charides for 30 min. In this experiment western blots of these cell
lysates were probed using antibodies speciﬁc for Akt phosphory-
lated at thr308 or ser473 as labeled. Following visualization the west-
ern blots were stripped and re-probed for total Akt or b-actin.
452 I. Schmitz et al.: Oligosaccharide stimulation of HAS-2order to elucidate the roles of these interactions in the main-
tenance of cartilage homeostasis. Thus, studying the chon-
drocyte responses to HA loss may shed light on our
understanding of cellular events that are associated with
the disease.HA oligosaccharides are thought to disrupt the spatial
clustering of CD44da clustering that is organized through
multivalent binding of high molecular mass HA to CD44 re-
ceptors26. Given that CD44 exhibits no intrinsic kinase or
phosphatase activity27 signal initiation is likely indirect, de-
pendent on changes in CD44-associated cytoskeletal ele-
ments or other components in the cell cortex. For
example, the time necessary to displace a cell-associated
Fig. 5. Effect of chemical inhibitors of signaling pathways on HA
oligosaccharide-mediated stimulation of pHAS2 (1932)-Luc activity
in transfected C-28/I2 cells. Panel A: Diagrammatic representation
of HAS-2 promoter construct, pHAS2 (1932)-Luc. The transcrip-
tional site is located near the end of the 5-untranslated region (50
UTR). The translational start site (AUG) is located at the start of
exon 2. The coordinates for the promoter represent bp position rel-
ative to the transcriptional start site. Panel B: C-28/I2 cells were ﬁrst
transiently transfected with pHAS2 (1932)-Luc, reduced to serum-
free conditions and then preincubated with or without the chemical
inhibitors, PD98059, SB203580, Helenalin, Wortmannin (Wort) or
LY294002, 30 min prior to, and during the addition of 250 mg/ml
HA oligosaccharides (þ) under serum-free conditions. The cells
were rinsed, solubilized with passive lysis buffer and analyzed for
luciferase activity using a luminometer. Values represent the aver-
age relative luciferase units (RLU)S.D. of data derived from trip-
licate cultures normalized to total protein. Fold increases following
HA oligosaccharide treatment, in control (no inhibitor), PD98059,
SB203580 and Helenalin conditions represented signiﬁcant
increases above control; P¼ 0.0248, 0.0002, 0.0013 and 0.0008,
respectively as measured using an unpaired Student’s t test.
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rides is between 1 and 2 h4. Previous studies in our labora-
tory have shown that the addition of HA oligosaccharides to
intact cartilage slices initiates a cascade of events that re-
sult in the loss of safranin O stainable proteoglycan, an in-
crease in NITEGE neoepitope within the tissue and, an
increase in MMPs and nitric oxide released into the me-
dium8,13e15. However, while the degradation of extracellular
matrix was evident, enhanced incorporation of 35S-sulfate
was observed. Similar HA oligosaccharide-initiated cas-
cades were also observed in cultures of isolated human
or bovine articular chondrocytes including a stimulation in
MMP-3, MMP-13 and inducible-nitric oxide synthase
mRNA, increases in w45e50 kD caseinolytic activity and
increased nitric oxide release13e15. Parallel with this stimu-
lated expression of catabolic genes, the HA oligosaccha-
rides also induced a stimulation in aggrecan, COMP,
collagen type II and HAS-2 mRNA8,9.
The question addressed in this study was whether the po-
tential anabolic, ‘‘repair’’ response of HAS-2 stimulation inresponse to HA oligosaccharide treatment occurred subse-
quent to the HA oligosaccharide stimulation of catabolic
gene products (e.g., MMPs and aggrecanases) or, whether
HAS-2 stimulation was the result of the activation of a sepa-
rate distinct pathway. Thus, given our previous data that HA
oligosaccharide stimulation of both MMP-3 and MMP-13
mRNA in chondrocytes requires at least 12 h of incuba-
tion15,16, while stimulation of HAS-2 occurs after 6 h, it sug-
gests that HAS-2 stimulation does not represent
a downstream consequence of chondrolysis mediated by
newly synthesized MMPs. If the stimulation of HAS-2
were a downstream event that followed the stimulation of
catabolic genes, blocking the pathways leading to the stim-
ulation of MMP-3 and MMP-13 would have resulted in
blocking the stimulation of HAS-2. The data outlined in
this study suggest that this does not occur. The stimulation
of HAS-2 involves the activation of the PI3K/Akt signaling
pathway, separate and distinct from the pathways responsi-
ble for the stimulation of MMP-3 or MMP-1315. It remains to
be determined if the PI3K/Akt pathway is involved in the ac-
tivation of other matrix genes by HA oligosaccharides. Ag-
grecan upregulation by IGF-I is part of the PI3K/Akt
pathway28. Additional details of the intracellular secondary
messengers involved in HA oligosaccharide-initiated signal-
ing remain to be more fully deﬁned. Nonetheless, it is clear
that some of the anabolic and catabolic responses by chon-
drocytes to HA oligosaccharides represent the activation of
different signaling cascades. Such information offers hope
that interventions could be designed that block the deleteri-
ous effects of damage/repair cycles while maintaining or
even enhancing aspects of cartilage matrix repair.Conﬂict of interest
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